Deepak Taneja

Deepak Taneja is a Senior Medical Director in Global Clinical Development at Regeneron, where they have focused on advancing clinical trials and implementing digital technology. With previous experience as the Global Medical Safety Director at The Janssen Pharmaceutical Companies of Johnson & Johnson and roles at Pfizer, Merck, and sanofi-aventis, Deepak has developed expertise in safety surveillance and pharmacovigilance. They also served as Medical Director for Neuro, Immuno, and Rare Disease at Sanofi Genzyme, leading initiatives to enhance diversity and inclusion in clinical studies. Deepak is currently pursuing education at Fairleigh Dickinson University's Silberman College of Business.